Lara Wynne Email and Phone Number
I have an exceptional track record of commercializing innovations and leading transformative growth for both startups and industry giants in biotech and medtech. My expertise covers a wide range of musculoskeletal areas including sports medicine, osteoarthritis, trauma, spine, orthopedic surgery, and acute and chronic musculoskeletal pain. I have broad experience leading and building cross-functional teams, centered on meaningful work, to advance novel, differentiated therapeutics, devices, biologics, injectables, technique driven procedures, and digital healthcare solutions to market for small start-ups as well as for giants in the industry. I'm known as a commercial go to market strategist with the ability to pivot when market dynamics demand a new approach. I have the vision to integrate a deep understanding of healthcare economics, government and private payor landscapes, and reimbursement policies to inform creative product positioning and market access strategy. Much of my success is due to my ability to form powerful relationships with customers and colleagues and build alignment.I am an entrepreneurial executive with a record of introducing innovations that have meaningfully advanced the practice of orthopaedics. I am driven by principle; my passion to serve the needs of clinicians, drive value, and advance patient care has earned the trust of thought leaders in the clinical community and a professional network that is unparalleled.I have a reputation for empowering colleagues, scientists, investors, and clinicians to lift their expectations, find new purpose, and achieve new levels of success. A leading surgeon commented “As a direct result of Lara’s influence our entire organization is delivering better and more effective care for patients.” I will continue to create great organizations and develop meaningful partnerships to improve healthcare for patients.
Allay Therapeutics
View- Website:
- allaytx.com
- Employees:
- 52
-
Allay Therapeutics -
Co-Founder And Chief Commercial OfficerGate Science, Inc. May 2020 - PresentCommercial Pre-Launch Strategy | Market Access Strategy | Investor Relations & Capital Raising | Team Builder | Marketing & Branding | Communications | SAB & Clinical Advocacy -
Board MemberGate Science, Inc. May 2022 - Present -
Chief Academic OfficerJournal Of Orthopaedic Experience & Innovation May 2022 - PresentBronx, UsBuilt Advisory Council & Editorial Board of National Leaders in Orthopaedics | Strategic Alliances with Medical Societies & Industry | Commercial Strategy | Program Development & Execution -
Vice President Academic DevelopmentJournal Of Orthopaedic Experience & Innovation Mar 2020 - May 2022Bronx, Us -
Independent ConsultantLara Wynne Consulting Llc Jun 2019 - PresentProvide ongoing strategic support relating to commercial strategy, market access, conference execution, KOL networking and curated strategic partnerships for biotech, specialty pharma, and medtech
-
National Director Key Accounts & Strategic AllianceFlexion Therapeutics Oct 2017 - May 2019Burlington, Massachusetts, UsLed national large account strategy for ZILRETTA (triamcinolone acetonide extended release), a novel specialty buy & bill injectable for osteoarthritis knee pain. Spearheaded major formulary wins in national accounts including Northwell, HSS, Cleveland Clinic, Duke, Rothman Institute, Medstar, Steadman Clinic, PRISMA Health, Stanford, Mass General, Geisinger... Built peer-to-peer advocacy program from ground up; assembled national speakers bureau to introduce new product & new company to the orthopedic market, assembled focus groups and scientific advisory boards to guide portfolio development & new product contextualization for the following assets:* FX-201 a gene therapy for osteoarthritis* FX-301 a NaV1.7 sensory selective sodium channel inhibitor for regional nerve blockMarket: orthopedic surgeons, rheumatologists, regional anesthesiologists, pain MDs, hospitals, private and academic practice -
Senior Commercial Surgical AccountsPacira Biosciences, Inc. May 2015 - Oct 2017Tampa, Florida, UsAward Winner | Sales Growth Leader | Major Formulary Wins | New Market Segments | Developed Impactful KOLs | Launch New InitiativesSales Leadership Committee | Opiate-Sparing Committee | Orthopaedic Cocktail Initiative Task Force | Shoulder & Sports Medicine Strategy Team | ASC Market Development Project | Oral Surgery Launch | Train the Trainer | Strategic Alliance TeamMarkets: orthopedic surgery (sports, shoulder, adult joint reconstruction, trauma & extremities), spine surgery, oral surgery, soft tissue surgery (general, breast, bariatric, colorectal, plastic, thoracic, ob/gyn), regional anesthesia, hospitals, surgery centers/ASCs -
Director Orthobiologics & Sports MedicineZimmer Biomet Jun 2013 - May 2015Warsaw, Indiana, UsLed Newly Established Early Intervention Division | Award Winning Achievement Leading Winning Team of 32 representatives | Unprecedented Sales Growth Across 4 Products | Impactful Strategic Launch of Subchondroplasty/Knee Creations & Gel-One | Recruited, Hired, Coached Team of Specialists Market: Orthopedic surgeons, hospitals, ASCs, surgical and clinic setting -
Senior Sales ManagerMammotome Mar 2012 - Jun 2013Cincinnati, Oh, UsLarge institutions- soft tissue and capital business growth achievement, physician advocacy* Breast biopsy devices (stereotactic, ultrasound, MRI imaging modalities), launched novel ultrasound biopsy device* Neoprobe Gamma Detection System for sentinel node biopsy (capital & disposables)Market: Breast surgeons, general surgeons, interventional radiologists, hospitals, surgical setting and private practice, surgical and clinical setting -
Surgical Accounts ManagerMedtronic Nov 2010 - Mar 2012Minneapolis, Mn, UsRecognized for outstanding achievement- major formulary wins, dramatic market growth and adoption, physician advocacy development for multiple specialtiesLaunched Aquamantys- novel bipolar radio frequency energy device for cutting & coagulation- blood management & improved visibility in surgical setting (capital & disposables)Market: orthopedic surgeons, spine surgeons, transplant surgeons, general surgeons, hospitals, surgical settingSalient Surgical Technologies launch- purchased by Medtronic in 2011. -
Senior Musculoskeletal Specialty Manager, National Field TrainerSanofi Genzyme Mar 2006 - Dec 2010Paris, France, FrPresident's club award winner YOY, clinician advocate developmentLaunched Synvisc-One, buy and bill and specialty pharmacy viscosupplement injectable device for OA Knee painMarket: orthopedic surgeons, rheumatologists, pain management physicians, private offices and hospital clinics -
Sales ConsultantDynasplint Systems, Inc. Jan 2002 - Mar 2006Severna Park, Maryland, UsPresident's Club- Bronze, Silver, Gold*Dynasplint- low load prolonged stretch device (DME) for orthopedic post-op range of motion and neurological tone & spasticityMarket: Orthopedic surgeons, physical therapists, physiatrists
Lara Wynne Education Details
-
Old Dominion UniversityMarketing
Frequently Asked Questions about Lara Wynne
What company does Lara Wynne work for?
Lara Wynne works for Allay Therapeutics
What is Lara Wynne's role at the current company?
Lara Wynne's current role is Dynamic and intuitive strategist with a record of commercializing innovations that have advanced the practice of orthopedics and pain management..
What schools did Lara Wynne attend?
Lara Wynne attended Old Dominion University.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial